Accarent Health's Commitment: Ensuring Equal Access to Premium Cardiovascular Care
19 oct. 2023 10h19 HE
|
Accarent Health
Baltimore, MD, Oct. 19, 2023 (GLOBE NEWSWIRE) -- According to the National Institute of Health, African American patients are 30% more likely to die from heart disease, and are at greater risk of...
Cyclarity Therapeutics Announces Clinical Advisory Board
17 oct. 2023 18h04 HE
|
Cyclarity Therapeutics
Cyclarity Therapeutics announce Clinical Advisory Board
Virtual Clinical Trials Market to Exceed USD 8.3 billion by 2032, Registering at a CAGR of 7.4% - Exclusive Report by Transparency Market Research
09 oct. 2023 07h01 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The virtual clinical trials market is projected to reach US$ 8.3 billion by 2032. Virtual...
Clinical Trials Market to Exceed USD 83.5 billion by 2030, Garnering 5.4% CAGR – Exclusive Report by Transparency Market Research
27 sept. 2023 08h13 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The clinical trials market was estimated to have acquired US$ 46.7 billion in 2019. It is...
Ligation Devices Market Size Worth USD 1.5 billion by 2028, Expanding at a CAGR of 6%: TMR Report
15 sept. 2023 09h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global ligation devices market is projected to flourish at a CAGR of 6% from 2020 to...
Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing
14 août 2023 02h00 HE
|
Xeltis
Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing Funding extends Xeltis’ Series D2 financing round to €44.5 million EINDHOVEN, The...
Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)
07 août 2023 07h00 HE
|
Amarin Corporation plc
-- VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within NHSScotland, as secondary prevention in adult statin-treated patients at high cardiovascular...
mHealth Market to Reach $370.7 Billion, Globally, by 2032 at 18.0% CAGR: Allied Market Research
01 août 2023 07h23 HE
|
Allied Market Research
Portland, OR, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report titled, “mHealth Market by Type (mHealth Devices and mHealth Services), Application (Cardiovascular,...
Generic Drugs Market to Reach $835.7 Billion, Globally, by 2032 at 8.1% CAGR: Allied Market Research
20 juil. 2023 11h36 HE
|
Allied Market Research
Portland, OR, July 20, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Generic Drugs Market By Therapeutic Application (Cardiovascular, Infectious Diseases, Cancer,...
Adhesion Barriers Market revenue to cross USD 3 Billion by 2033, says Research Nester
06 juil. 2023 07h00 HE
|
Research Nester
New York, July 06, 2023 (GLOBE NEWSWIRE) -- The global adhesion barriers market is estimated to grow at a CAGR of ~8% from 2023 to 2033. The market is estimated to garner a revenue of ~USD 3 billion...